Carelon Research and Manifold Partner to Expand Real-World Evidence Access for Life Sciences Researchers
Carelon Research, a subsidiary of Elevance Health, and Manifold, an enterprise agent platform for life sciences, today announced a strategic partnership that gives life sciences researchers and data analysts secure, scalable access to high-quality, analysis-ready, real-world data in a protected environment, enabling faster, evidence-based decision-making.
Through this collaboration, users can analyze Carelon Real World Data (RWD) alongside third-party datasets without moving data outside their respective organizations, reducing risk and strengthening data protection. The partnership also enables users to link Carelon RWD with additional datasets to address evidence gaps for specialized analyses.
“Organizations are under increasing pressure to generate timely real-world evidence and insights, while maintaining standards of data security and compliance,” said Mark Cziraky, president of Carelon Research. “This partnership represents an important advancement in how life sciences teams can access and interact with high-quality, analysis-ready, real-world data. By combining the scale and depth of Carelon Real World Data with a secure, intuitive analytics platform, we are helping our partners translate data into meaningful, actionable insights faster.”
